The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis ; volume:15 ; number:1 ; day:9 ; month:4 ; year:2020 ; pages:1-15 ; date:12.2020
Radiation oncology ; 15, Heft 1 (9.4.2020), 1-15, 12.2020
- Creator
-
Jin, Liang
Shi, Ning
Ruan, Shiye
Hou, Baohua
Zou, Yiping
Zou, Xiongfeng
Jin, Haosheng
Jian, Zhixiang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01511-9
- URN
-
urn:nbn:de:101:1-2020062521070797458537
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jin, Liang
- Shi, Ning
- Ruan, Shiye
- Hou, Baohua
- Zou, Yiping
- Zou, Xiongfeng
- Jin, Haosheng
- Jian, Zhixiang
- SpringerLink (Online service)
Other Objects (12)
Intraoperative radiation therapy (IORT) in pancreatic cancer
Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
Intraoperative radiation therapy induces immune response activity after pancreatic surgery
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
Intraoperative radiation therapy : proceedings
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Preoperative predictors for early recurrence of resectable pancreatic cancer
Upfront Surgery versus Neoadjuvant Therapy for Resectable Pancreatic Cancer: Systematic Review and Bayesian Network Meta-analysis
Intraoperative radiation therapy (IORT) in pancreatic cancer
Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
Intraoperative radiation therapy induces immune response activity after pancreatic surgery
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
Intraoperative radiation therapy : proceedings
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Preoperative predictors for early recurrence of resectable pancreatic cancer
Upfront Surgery versus Neoadjuvant Therapy for Resectable Pancreatic Cancer: Systematic Review and Bayesian Network Meta-analysis
Intraoperative radiation therapy (IORT) in pancreatic cancer
Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
Intraoperative radiation therapy induces immune response activity after pancreatic surgery
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
Intraoperative radiation therapy : proceedings
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Preoperative predictors for early recurrence of resectable pancreatic cancer